recent
Fluence Webinar to Explore Principles of Psychotherapeutic Touch in Psychedelic Therapy
After ‘Positive’ FDA Meeting, Cybin Looks Ahead to Phase 3 CYB003 Program
Madrigal Mental Care Completes Nanotechnology Research on Ketamine
FDA Grants MindMed’s LSD Formulation Breakthrough Designation
